These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37934312)

  • 1. Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study.
    Duivon M; Lange M; Binarelli G; Lefel J; Hardy-Léger I; Kiasuwa-Mbengi R; Méric JB; Charles C; Joly F
    J Cancer Surviv; 2024 Dec; 18(6):1974-1997. PubMed ID: 37934312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Delphi technique toward the development of a cognitive intervention framework module for breast cancer survivors with cognitive impairment following chemotherapy.
    Syed Alwi SM; Mazlan M; Mohd Taib NA; Che Din N; Narayanan V
    PLoS One; 2022; 17(11):e0277056. PubMed ID: 36395277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-related cognitive impairment: updates to treatment, the need for more evidence, and impact on quality of life-a narrative review.
    Yang Y; Von Ah D
    Ann Palliat Med; 2024 Sep; 13(5):1265-1280. PubMed ID: 39260437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian oncology health professionals' knowledge, perceptions, and clinical practice related to cancer-related cognitive impairment and utility of a factsheet.
    He S; Lim CYS; Dhillon HM; Shaw J
    Support Care Cancer; 2022 Jun; 30(6):4729-4738. PubMed ID: 35122530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Experience of Cancer-Related Cognitive Impairment Across Common Cancers: Protocol for a Qualitative Systematic Review.
    Ibrar M; Rai HK; Main A; McCartney H; Maguire R; Rodriguez MAP
    JMIR Res Protoc; 2024 May; 13():e56888. PubMed ID: 38820581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
    Chung NC; Walker AK; Dhillon HM; Vardy JL
    Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective non-pharmacological interventions for cancer related cognitive impairment in adults (excluding central nervous system or head and neck cancer): systematic review and meta-analysis.
    Mackenzie L; Marshall K
    Eur J Phys Rehabil Med; 2022 Apr; 58(2):258-270. PubMed ID: 34498828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A modified Delphi survey to build expert consensus on the structure and content of an enhanced care pathway for cognitive changes after stroke in the UK.
    Hobden G; Tang EYH; Demeyere N
    BMC Health Serv Res; 2024 Oct; 24(1):1162. PubMed ID: 39354449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-related cognitive impairment in non-CNS cancer patients: Targeted review and future action plans in Europe.
    ; Sleurs C; Amidi A; Wu LM; Kiesl D; Zimmer P; Lange M; Rogiers A; Giffard B; Binarelli G; Borghgraef C; Deprez S; Duivon M; De Ruiter M; Schagen S; Ahmed-Lecheheb D; Castel H; Buskbjerg CR; Dos Santos M; Joly F; Perrier J
    Crit Rev Oncol Hematol; 2022 Dec; 180():103859. PubMed ID: 36257539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of rehabilitation programs for cognitive impairment related to breast cancer: Different programs at different times?
    Merceur M; Reilly KT; Bonan I; Holé J; Hummel E; Cogné M; Jacquin-Courtois S
    Ann Phys Rehabil Med; 2024 Jun; 67(5):101832. PubMed ID: 38537525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Acupuncture on Cancer-Related Cognitive Impairment in Chinese Gynecological Cancer Patients: A Pilot Cohort Study.
    Zeng Y; Cheng ASK; Song T; Sheng X; Wang S; Xie J; Chan CCH
    Integr Cancer Ther; 2018 Sep; 17(3):737-746. PubMed ID: 29806502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-based biomarkers of cancer-related cognitive impairment in non-central nervous system cancer: protocol for a scoping review.
    Mayo SJ; Kuruvilla J; Laister RC; Ayala AP; Alm M; Byker W; Kelly DL; Saligan L
    BMJ Open; 2018 Jan; 8(1):e017578. PubMed ID: 29374660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-related cognitive impairment in survivors of adolescent and young adult non-central nervous system cancer: A scoping review.
    Vizer LM; Mikles SP; Piepmeier AT
    Psychooncology; 2022 Aug; 31(8):1275-1285. PubMed ID: 35726379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-related cognitive impairment: a mixed methods evaluation of a standard factsheet.
    Lim CYS; He S; Shaw J; Dhillon HM
    Support Care Cancer; 2022 Mar; 30(3):2375-2385. PubMed ID: 34741655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of mindfulness on cancer-related cognitive impairment in breast cancer survivors with cognitive complaints.
    Melis M; Schroyen G; Leenaerts N; Smeets A; Sunaert S; Van der Gucht K; Deprez S
    Cancer; 2023 Apr; 129(7):1105-1116. PubMed ID: 36625501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive functioning and work-related outcomes of non-central nervous system cancer survivors: protocol for a systematic review with meta-analysis.
    Oliveira AF; Fernandes S; Reis JD; Torres A; Santos IM; Von Ah D
    BMJ Open; 2022 Jul; 12(7):e060300. PubMed ID: 35820744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical diagnosis of symptomatic forefoot neuroma in the general population: a Delphi consensus study.
    Dando C; Cherry L; Jones L; Bowen C
    J Foot Ankle Res; 2017; 10():59. PubMed ID: 29299065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers.
    Tan CJ; Mah JJJ; Goh WL; Poon E; Harunal Rashid MF; Chan A
    Psychooncology; 2020 Aug; 29(8):1355-1362. PubMed ID: 32597001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.
    Treanor CJ; McMenamin UC; O'Neill RF; Cardwell CR; Clarke MJ; Cantwell M; Donnelly M
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011325. PubMed ID: 27529826
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.